People with sickle cell disease experience excruciating pain crises, tissue and organ damage, and shortened life expectancy. The lab of Stuart Orkin made crucial discoveries that, in the hands of CRISPR Therapeutics and Vertex Pharmaceuticals, became an FDA-approved gene therapy that is making a monumental impact on patients with sickle cell disease.
Related Posts
Why Boosting Potassium Is Key for Better Blood Pressure Control
August 17, 2026
Learn how increasing potassium can enhance blood pressure control when paired with salt reduction. Discover practical dietary tips for heart health.
Can Eating Tomatoes Reduce Liver Fat? What New Research Reveals
August 10, 2026
A new study hints that daily tomato consumption may reduce liver fat buildup in MASLD patients. Learn what this means for your health.
How a Lesser-Known SARS-CoV-2 Protein May Explain Long COVID Symptoms
August 10, 2026
Discover how a UCLA study sheds light on the nucleocapsid protein's role in long COVID, revealing key mechanisms of tissue damage and potential therapies.
AI Unlocks Targeted Treatment for Locally Advanced Rectal Cancer Patients
August 3, 2026
UCL researchers utilize AI to tailor treatments for rectal cancer, identifying patients who benefit most from intensified regimens. Discover the breakthrough.